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equipment costs (depreciation of equipment); medication-error and complication
costs including bloodstream-infection (BSI) costs. Total costs were calculated per
bag for neonates and infants. Data and resources utilized were derived from three
Belgian hospitals. Medication-error and BSI costs were derived via literature. A
bottom-up approach was used to assess total costs by assigning monetary values to
the resource-utilization using published list prices, literature and interview data.
RESULTS: The daily total cost of one compounded PN bag for neonates equaled
90.19€. Overall, labor costs accounted for 42% of total costs and represented the
highest proportion, followed by costs due to medication-error and incremental BSI
costs (22%). Disposables accounted for 22% and nutrients for 12%. Average costs per
bag for infants 2yr were 108.37€, with labor costs also representing the highest
proportion (35%). Nutrients represented 27% of total costs, while medication-error
and incremental BSI costs accounted for 19% and disposables for 18%.
CONCLUSIONS: This is the first time that complete costs of PN have been considered,
including consequential costs of medication-error and BSI costs. The data showed that a
significant proportion of the total costs of PN is due to these costs as well as labor costs.
Ready prepared PN could reduce staff-time, error and infection rates.
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OBJECTIVES: Syncope represents about 2% of Emergency Room (ER) admissions.
The European Society of Cardiology (ESC) published in 2009 Guidelines for the
diagnosis/management of syncope. Several studies have tried to investigate Guide-
lines adoption and clinical pathways for syncope care. The first objective of PROSIT
was to relate syncope management in Italian hospitals, including clinical out-
comes and costs. METHODS: This is a retrospective, longitudinal (6 months), mul-
ticenter study, considering every patients (pts) admitted in ER with the diagnosis of
syncope. Data about ER, laboratory tests, hospitalizations, final diagnosis and re-
lated costs from the Regional Health Service (RHS) were considered since the ER
admission till the hospital discharge RESULTS: A total of 1,632 pts (mean age: 61;
SD23 ) were recruited in 9 Italian hospitals. A mean of 4.5 laboratory tests per
patient during ER stay were performed; unfortunately many pts did not undergo
specific tests for syncope (e.g. ECG monitoring and carotid sinus massage) recom-
mended by ESC guidelines. 40,3% of pts without definitive diagnosis were hospi-
talized in ER department. The mean cost of ER tests and ER hospitalizations was
174.09€ per patient. 28% of pts was admitted in different hospital departments
(after first ER evaluation), with mean stay of 9 days (SD6). The cost sustained was
571.39 € per patient. The 35% of patients with syncope remained undiagnosed after
ER or hospitalization discharge, with 26% of total costs sustained for these patients.
CONCLUSIONS: Different approaches to achieve syncope diagnosis were founded
in PROSIT study. The diagnosis of syncope has a clinical and significant impact on
costs. Hospitalizations, for which the majority of costs are sustained, help to find a
diagnosis but a greater adherence to guidelines could reduce undiagnosed syn-
cope, actually still elevated, and related costs due to diagnostics and inappropriate
admissions.
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OBJECTIVES: Achieving optimal patient adherence to IV medication is a major
challenge in clinical management of chronic diseases. The objectives of this liter-
ature review were to identify the factors that influence patient non-adherence to IV
medication for chronic conditions and evaluate if an optimum relationship be-
tween dosing frequency and adherence exists. METHODS: A database search for
adherence to IV medication was conducted through Medline, Embase and Biosis
databases. Inclusion and exclusion criteria were applied before each published
article or abstract (1990-May 2012) was appraised. Primary research studies, in
English language, with an analysis of adherence rates and or factors in a chronic
condition were included. RESULTS: Twelve primary studies were identified and
reviewed across two chronic conditions: osteoporosis (8) and Crohn’s Disease (4).
Multiple patient-related and therapy-related factors were reported to influence
non-adherence to IV medication. The most frequently identified factors influenc-
ing non-adherence were therapy-related: poor tolerability and side effects (3 stud-
ies) and inconvenience of location for therapy (3 studies). In two studies comparing
directly IV dosing frequency in osteoporosis therapy, adherence was greater for
annual therapy vs every 3 months (82% vs 58-62% and 65.6% vs 56.6% respectively).
There was a wide range in the reported rate of non-adherence across studies in
both osteoporosis and Crohn’s Disease (17.1% to 43.4% and 27% to 40%, respec-
tively). A threshold for IV dosing frequency that optimises adherence could not
clearly be assessed. CONCLUSIONS: Dosing frequency appears to be one determi-
nant of non-adherence among chronic diseases along with multiple other factors,
most notably tolerability and convenience. Further primary research is required to
determine the relative influence of IV dosing frequency and other therapy-related
factors in management of specific chronic diseases in clinical practice.
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OBJECTIVES: To determine the association between potentially inappropriate pre-
scribing (PIP) defined by STOPP (Screening Tool of Older Person’s PIP) and adverse
drug events (ADEs), health related quality of life (HRQOL) and hospitalisation in
older primary care patients. METHODS: A cross-sectional study of 904 patients
aged 70 years recruited from 15 general practices in Ireland in 2010. PIP was
defined by the STOPP criteria. ADEs defined as any injury resulting from drug
therapy, were measured by patient self-report for the previous 6 months and re-
viewed by two independent clinicians. HRQOL was measured by the EQ-5D and
utility values calculated based on UK population values. Hospitalisation was mea-
sured using patients’ medical records and self-report. Multilevel logistic, linear and
poisson regression was used to examine how ADEs, utility and hospitalisation
varied by PIP after adjusting for patient and practice level cofounding variables
including socioeconomic status, co-morbidity, number of different repeat drug
classes and adherence. Adherence was measured by the medication possession
ratio using patients’ national pharmacy claims data and self-report. RESULTS: The
overall prevalence of PIP was 42% (n377). Patients with 2 PIP indicators were
twice as likely to have an ADE (OR, 2.21; 95% CI, 1.02, 4.83, p0.05), had a signifi-
cantly lower mean HRQOL utility (coefficient, -0.11, SE 0.03, p0.001) and a 34%
increase in the expected rate of hospitalisation (IRR, 1.34; 95% CI, 1.15, 1.57,
p0.001) after adjustment. The number of repeat drug classes and adherence were
also significantly associated with ADEs, impaired HRQOL and increased
hospitalisation. CONCLUSIONS: PIP defined by the STOPP criteria was significantly
associated with patient reported ADEs, HRQOL and hospitalisation. There is limited
data regarding the association between PIP and adverse health outcomes in older
patients. Studies are important to facilitate the design of better interventions to
improve medication safety in older patients.
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OBJECTIVES: Medication non-adherence is associated with poorer health status;
yet, intentional (INA; e.g., purposefully skipping doses) and unintentional (UNA;
e.g., forgetting) non-adherence levels may differ across disease areas and associ-
ated therapies. This study investigated non-adherence across prevalent conditions
in a Russian patient population. METHODS: Russia 2011 National Health and Well-
ness Survey data included 2,285 (of 10,039) respondents who completed the
Morisky Medication Adherence Scale (MMAS) for the following treated conditions:
pain, arthritis, asthma, depression, diabetes, and hypertension. MMAS items were
summed to create INA (“stop taking medicine when feeling better” and “. . .when
feeling worse”) and UNA (“forget to take medicine” and “careless about taking
medicine”) scores: 0adherence to 2high non-adherence. Logistic regressions
predicted INA/UNA (1 vs. 0) from condition, gender, age, Charlson Comorbidity
Index score, BMI category, marital status, exercise 12 times monthly, and ciga-
rette smoking. RESULTS:Among patients reporting MMAS for pain (n719), arthri-
tis (n209), asthma (n87), depression (n177), diabetes (n87), and hypertension
(n1,006), 51.3% were male, mean age was 49.3 years (SD16.2), and 77.7% and
52.3% exhibited INA and UNA, respectively (rINA/UNA0.36, p0.001). Pain had the
highest INA rate (89.2%). Diabetes had the lowest non-adherence
(INAUNA44.8%). Asthma had low UNA (41.4%). Depression had the highest UNA
(66.6%) and second-highest INA (81.4%). Adjusting for covariates, respondents in
any condition vs. pain had lower relative odds of INA, from OR0.12 (diabetes) to
0.52 (depression), all p0.01; respondents with arthritis and depression vs. pain
had higher relative odds of UNA (OR1.45 and 1.74, respectively), both p0.05.
Covariates of INA were non-significant. Younger age, lack of exercise, male sex,
obesity, and recent divorce/separation/widowhood were associated with UNA, all
p0.05. CONCLUSIONS: High, varying levels of non-adherence were found across
prevalent conditions in Russia. Adherence may be improved by matching pharma-
cotherapy profiles to specific conditions (e.g., favorable tolerability for high-INA
conditions such as pain).
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OBJECTIVES: To measure the impact of periods on the lives of women reporting a
problem, through the use of health related quality of life instruments in a real-
world setting. METHODS: The evaluation was conducted throughout the UK using
the web-based PROBE system (patient reported outcomes based evaluation). As
women may not seek professional health care advice for this issue, recruitment
was tailored to identify a sample representative of all women with problem peri-
ods. An initial screening questionnaire was used to programme the timing of the
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questionnaires (main evaluation). Questionnaires were completed around men-
struation and mid-cycle in the same individual. Outcome measures included de-
mographic data, symptoms, previous treatments, current medications, absentee-
ism, presenteeism, HRQoL using SF-36 and EQ-5D. Women with irregular periods or
bleeding were not invited to the main evaluation due to difficulty timing question-
naire completion. RESULTS: A total of 2699 women participated in the screening
questionnaire. 61% of screened women were under 30 years, half had sought med-
ical advice and 25% were currently self-medicating for their periods. Patients were
severely affected as noted on the following measures. Symptoms: 84% report phys-
ical symptoms, 78% psychological symptoms and 41% bleeding issues. Absentee-
ism: 21% take  1-2 days off per month due to their period. Presenteeism: 33%
reduction in workplace performance versus referent populations. 331 women par-
ticipated in the main evaluation. From this, there was a significant difference in
HRQoL between the worst and best times of the menstrual cycle: EQ5D question-
naire 0.57 to 0.76 (difference 0.167, p0.001); EQ5D VAS 64.3 to 77.7 (difference 11.0,
p0.001); SF6D 0.61 to 0.72 (difference 0.1, p0.001). CONCLUSIONS: This evalua-
tion shows that women suffering from problem periods have a significant impair-
ment of their QoL and productivity in spite of treatment. A need exists for treat-
ment that can alleviate these symptoms, enable more productive lives and
improve the overall quality of life in these women.
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OBJECTIVES: Asthma, chronic obstructive pulmonary disease (COPD), rheumatoid
arthritis (RA) are chronic conditions with different prevalence, mortality, effect on
patient’s quality of life (QoL). The aim of this study was to compare the human
capital loss and utility of patients in these conditions with the general Hungarian
population; and to estimate the impact of utility decrement and disease specific
mortality on the overall health burden in these diseases. METHODS: QoL was as-
sessed with the EuroQoL EQ-5D in cross sectional non-interventional studies. Over-
all annual health loss due decreased QoL was estimated by multiplying number of
patients with the utility decrement. Overall annual years of life loss due premature
mortality was calculated by multiplying crude age/disease/gender specific mortal-
ity with age/gender specific life expectancy, age/disease/gender specific utility and
the number of inhabitants in the age cohort. The aggregation of these expressed
the total annual health loss in quality adjusted life years (QALYs). RESULTS:A total
of 869 consecutive patients were recruited (402 with asthma, 214 with COPD and
253 with RA). Utility values among patients were significantly lower compared to
the general population in all age cohorts (p0.001). RA was associated with signif-
icantly lower utilities compared to asthma between the ages of 45 to 64, and com-
pared to COPD between the ages of 45 to 74 (p0.05). There was, however, no
significant difference between QoL of the two respiratory disorders. Based on con-
servative estimates (e.g. considering age between 45-84), asthma, COPD and RA
contribute to a total annual health loss of 20905, 66911 and 10660 QALYs in Hun-
gary, respectively. CONCLUSIONS: The three conditions result in considerable
QALY loss to the Hungarian society. Our results outline the importance of the
overall health burden calculations, since utility decrement has a significant impact
on Human capital loss and provides important data for decision makers.
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OBJECTIVES: In theory, time preference, or discounting, affects health-state valu-
ation using the time trade-off (TTO) method. This study aimed to determine indi-
viduals with different time preferences in the general US population using the
latent class analysis (LCA). METHODS: LCA was performed with valuation data
from the US Valuation of EQ-5D Health States Study. In that study, 42 EQ-5D-3L
health states and ‘unconsciousness’ were categorized into 5 blocks for each re-
spondent to value one randomly selected block of health states (n13). Separate
LCA was conducted for respondents valuing the same block of health states.
RESULTS: Modeling outputs were consistent across the 5 subgroups. The 3-class
model was adopted to reflect the hypothesized effects of time preferences on val-
uations. The first class (size: 53.1% of the general US population) was recognized as
the average individuals. The mean health-state preference scores derived from this
class ranged from -0.185 to 0.920. The second class (size: 34.4%) was a group of
individuals with a low time preference. The mean health-state preference scores
ranged from 0.056 to 0.963. Compared with those in class one, individuals in class
two were more likely to be Hispanic or black, married or never married, and com-
ment that the TTO valuation tasks was very easy to do. The third class (size: 12.5%)
comprised individuals with a high time preference. The mean health-state prefer-
ence scores derived from this class ranged from -0.605 to 0.655. Individuals in this
class were older and more likely to be female, Hispanic, poorly educated, with
lower income, and divorced or widowed. CONCLUSIONS: This study provides evi-
dence for the existence of individuals with high and low time preferences in the
general US population. Future valuation studies using the TTO method should
explicitly measure respondents’ time preferences and investigate the effects of
time preferences on health-state valuations.
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OBJECTIVES: To estimate the disability-adjusted life years (DALYs) lost in a nation-
wide representative sample of postmenopausal women with osteoporosis. Effect of
previous bone fracture and type of drug-based therapy of osteoporosis were also
explored. METHODS: DALYs were estimated based on patients’ clinical character-
istics and Health-Related Quality-of-Life (HRQoL) data from a cross-sectional, epi-
demiological one-visit study (the GINERISK study). The study enrolled postmeno-
pausal women (at least 12-month after last menstrual period) with osteoporosis,
above 18-years old, who were attending outpatient clinics of Gynecology in Spain.
Socio-demographics, bone densitometry (BD) and HRQoL were recorded. HRQoL
was assessed using the generic SF-12v2 questionnaire, which was used to derive
disutility values. Mortality rates were extracted from the Spanish national statis-
tics database. DALY=s were calculated according to Fox-Rushby and Hanson (2001)
and ANCOVA models, adjusted for age, BD, previous osteoporotic bone fractures
(BF), treatment with calcium or calciumvitamin D, exercise and number of risk
factors for osteoporosis, were used for comparative purposes. RESULTS: DALYs
could be computed in 2,782 (67%) out of 4,157 postmenopausal women, with a
mean (95% CI) age of 61.0 (60.7-61.2) years. Mean overall undiscounted DALY=s lost
per women were 6.1 (5.9-6.2), with a significantly higher loss in women with pre-
vious BF; 7.8 (7.2-8.4) in comparison with women without BF [5.8 (5.6-6.0)] or osteo-
porotics with a BD-2.5 T-score after receiving a drug-based therapy [6.2 (5.8-6.5)];
F27.0 (P0.01). A model explaining the variation in the levels of health was found
which included the use of a SERM-based therapy, age, previous osteoporotic BF and
the number of risk factors for osteoporosis as significant predictors (P  0.05).
CONCLUSIONS: DALY=s loss was considerable amongst postmenopausal women
with osteoporosis. The use of a SERM, not having previous osteoporotic bone frac-
ture, having less osteoporotics risk factors and being older showed to be linked to
less DALY=s lost.
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OBJECTIVES: To measure Health Related Quality of Life among Pharmacy students
at the Medical University of Warsaw and compare results for years 2010-2012.
METHODS: In the same period of years 2010-2012, students from the Faculty of
Pharmacy, Medical University of Warsaw were surveyed with a set of HRQoL ques-
tionnaires. The survey was conducted in the middle of the semester, when stu-
dents have no exams, nor tests and was a part of long-term Pharmacoeconomic
Student Chapter’s project. Students self-completed pen and pencil versions of
questionnaires and didn’t receive any compensation. They were asked to give
information regarding sex, age, year of study, average grade during the previous
year of study and to complete final official Polish version of EQ-5D-5L, followed by
EQ-VAS, SF-36v.1 and EQ-5D-3L. RESULTS: In the study period, 444, 369 and 364
students responded from each year respectively and the results were included in
the final analysis. Concerning SF-36 dimensions, students reported major prob-
lems in vitality; 52.5415.19; 53.3218.17; 46.6718.23 as opposed to physical func-
tioning 96.573.75; 95.648.28; 94.159.39. Mean rate of own health on EQ-VAS
was 79.2310.61; 80.1315.00; 76.0517.30 and mean EQ-5D index, based on Polish
TTO value set, was 0.940.07; 0.940.07; 0.910.11 (in the range from -0.523 to 1). In
2010 and 2011 students of 3rd year and 1st year reported lowest QoL independently
of the measure used: EQ-VAS and EQ-index, respectively. In 2012 students of 2nd
year reported lowest QoL measured by EQ-VAS 70.3320.63 and 3rd year measured
by EQ-index 0.890.13. CONCLUSIONS: Generic questionnaires used in the survey
are sensitive enough for measuring quality of life in young and relatively healthy
population. Assessment of HRQoL was similar in years 2010 and 2012. The survey
needs to be continued next year.
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OBJECTIVES:To investigate trends of the quality of life in South Korean adults aged
19 and older using Korean National Health and Nutrition Examination Survey
(KNHANES).METHODS: This study used the 2007-2010 Korean National Health and
Nutrition Examination Survey (KNHANES), a nation-wide survey on various health-
related questions for a nationally representative sample of the non-institutional-
ized population of South Korea. Quality of life (QOL) was measured using the EQ-5D
instrument and the QOL index scores were calculated based on Korean version of
the score calculation algorithm. Trends of QOL index and factors influencing QOL
index scores were analyzed using analysis of variance and ordinal least square
regression after adjusting for the study variables. RESULTS: A total of 23,777 adults
were identified during 2007 to 2010. Mean age was 44.7 years and 50.5% were female
and 68% were graduated from high schools or colleges and 31% had the body mass
index 25. Hypertension was most prevalent chronic disease (16.5%), followed by
arthritis (13.3%), hyperlipidemia (7.0%), and diabetes (6.3%). The overall EQ-5D in-
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